Current position:Home >Product >
N-(4-(3-bromophenylamino)-7-methoxyquinazolin-6-yl)-2-(piperidin-4-ylidene)acetamide
N-(4-(3-bromophenylamino)-7-methoxyquinazolin-6-yl)-2-(piperidin-4-ylidene)acetamide(1005195-05-0)
- Name: N-(4-(3-bromophenylamino)-7-methoxyquinazolin-6-yl)-2-(piperidin-4-ylidene)acetamide
- Synonyms:
- Molecular Formula:
- Molecular Weight:468.353
- CAS Registry Number:1005195-05-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1146432-92-9/1-(3,5-dichloro-phenyl)-3-[3-methyl-4-(2-methyl-[1,3']bipyrrolidinyl-1'-yl)-phenyl]-urea trifluoroacetate
- 1136480-51-7/N2-(2-Methoxy-benzyl)-N6-(3-piperidin-1-yl-[1,2,4]oxadiazol-5-yl)-quinoline-2,6-diamine
- 1144073-36-8/1-[4-(hydroxymethyl)phenyl]-3-{4-[1-(4-methoxycyclohexyl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}urea
- 1049097-09-7/1-[4-(Methyloxy)piperidin-1-yl]-3-(3-{3-[(2-oxo-2-pyrrolidin-1-ylethyl)sulfanyl]-4-(trifluoromethyl)phenyl}-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)propan-2-ol
- 1061644-85-6/(S)-3-cyclohexyl-2-(2-oxo-4-(3,3,3-trifluoropropylsulfonyl)piperazin-1-yl)-N-(thiazol-2-yl)propanamide
- 1061645-63-3/(S)-4-(3-cyclohexyl-1-oxo-1-(thiazol-2-ylamino)propan-2-yl)-3-oxo-N-(4-(trifluoromethyl)phenyl)piperazine-1-carboxamide
- 1101147-85-6/C20H21Cl2FN4O
- 1104270-27-0/N-({1-[(3R)-3-aminopyrrolidin-1-yl]cyclohexyl}methyl)-2-pyrimidin-2-yl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide
- 1109294-29-2/N-hydroxy-4-{5-[4-(5-amino-2-pyridin-3-ylthiazol-4-yl)phenoxy]pentyloxy}benzamidine
- 1095542-35-0/1-(2-fluoro-3,4-dimethoxyphenyl)piperazine
- 1094617-98-7/(S)-O-methyl (3-(4-(4-(cyclopropane-carbonyl)-piperazin-1-yl)-3-fluoro-phenyl)-2-oxo-oxazoIidin-5-yl)-methyl-carbamothioate
- 1114974-16-1/{4-[4-(ethyl)-9-(ethyloxy)-1,3-dioxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]phenyl}acetic acid
- 1115590-96-9/N-(1-cyclohexyl-2-{[4-(hydroxymethyl)phenyl]amino}-2-oxoethyl)-2-(1H-indol-3-yl)-2-oxo-N-(3-pyrrolidin-1-ylpropyl)acetamide
- 1119777-90-0/C33H47N2O10P
- 1146701-46-3/1H-indole-6-carboxylic acid [2-methyl-4-(2-methyl-[1,3']bipyrrolidinyl-1'-yl)-phenyl]-amide
- 936017-97-9/N-Methyl-4-trifluoromethoxy-N-[4-(1,3,3-trimethyl-6-aza-bicyclo[3.2.1]octane-6-carbonyl)-benzyl]-benzamide
- 1123213-34-2/4,5-dihydroxy-2-[(3-chloro-4-fluorophenyl)methyl]-1H-isoindole-1,3(2H)-dione
- 929091-41-8/{3-(2-methoxy-ethoxy)-5-[4-(pyridin-4-ylsulfanyl)-benzenesulfonyl]-phenyl}-acetic acid
- 1131346-33-2/C28H33N3O3*ClH
- 1005195-05-0/N-(4-(3-bromophenylamino)-7-methoxyquinazolin-6-yl)-2-(piperidin-4-ylidene)acetamide
- 1146624-39-6/1,1'-(1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-2,2'-binaphthyl-5,5'-diyl)bis(2-p-tolylethanone)
- 1126432-72-1/1-acetyl-N-{4-[4-[3,5-bis(methyloxy)phenyl]-2-(ethylamino)-1,3-oxazol-5-yl]-2-pyrimidinyl}-2,3-dihydro-1H-indol-6-amine
- 1140460-95-2/3-(2-methoxyphenyl)-5-(3-nitro-4-pyrrolidin-1-ylphenyl)-1,2,4-oxadiazole
- 1140461-00-2/1-{4-[3-(2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-2-nitrophenyl}azepane
- 1142938-06-4/C19H16N6O
- 1142939-44-3/C26H29N5O3
- 1034375-02-4/C15H19N3O5
- 1178584-16-1/C13H17BrO2
- 1261289-43-3/2-[(4-chlorophenyl)methyl]-5-[[4-(trifluoromethyl)phenyl]amino]-2,3-dihydro-1,2,4-thiadiazol-3-one
- 1262419-48-6/2-(2-chlorophenyl)-6-((S)-quinuclidin-3-yl)-5,6-dihydroimidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one